Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iannis Aifantis

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Nature Immunology|September 5, 2025
The pre-T cell receptor as a tumor immunotherapy target in T cell leukemiaAliza Rosen, Iannis Aifantis
Current Opinion in Genetics & Development|December 13, 2016
Alternative roles for oxidized mCs and TETsLuisa Cimmino, Iannis Aifantis
Cell Cycle (Georgetown, Tex.)|November 26, 2009
Hedgehog and hematopoietic stem cell differentiation: don't believe the hype!Jie Gao, Iannis Aifantis
Blood Cancer Discovery|December 12, 2025
(Sub)Clonal Wars: Interferon Interference Yields the Upper HandDimitrios Papaioannou, Iannis Aifantis
Blood Cancer Discovery|April 23, 2024
Hematopoietic Clonal Evolution Goes SpatialRebecca Austin, Iannis Aifantis
Nature Immunology|September 16, 2025
Publisher Correction: The pre-T cell receptor as a tumor immunotherapy target in T cell leukemiaAliza Rosen, Iannis Aifantis
Nature Cancer|February 5, 2022
LILRB3 as a regulator of AML survivalAudrey Lasry, Iannis Aifantis
Cancer Cell|March 12, 2015
The pre-BCR to the rescue: therapeutic targeting of pre-B cell ALLThomas Trimarchi, Iannis Aifantis
Blood|January 2, 2025
Vitamin C deprivation puts stem cells to sleepJuan Carlos Balandrán, Iannis Aifantis
Cancer Cell|September 15, 2020
U.S. Biomedical Research Needs More Immigrant Scientists, Not Fewer!Iannis Aifantis, Benjamin G Neel
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Nature Immunology|September 5, 2025
The pre-T cell receptor as a tumor immunotherapy target in T cell leukemiaAliza Rosen, Iannis Aifantis
Current Opinion in Genetics & Development|December 13, 2016
Alternative roles for oxidized mCs and TETsLuisa Cimmino, Iannis Aifantis
Cell Cycle (Georgetown, Tex.)|November 26, 2009
Hedgehog and hematopoietic stem cell differentiation: don't believe the hype!Jie Gao, Iannis Aifantis
Blood Cancer Discovery|December 12, 2025
(Sub)Clonal Wars: Interferon Interference Yields the Upper HandDimitrios Papaioannou, Iannis Aifantis
Blood Cancer Discovery|April 23, 2024
Hematopoietic Clonal Evolution Goes SpatialRebecca Austin, Iannis Aifantis
Nature Immunology|September 16, 2025
Publisher Correction: The pre-T cell receptor as a tumor immunotherapy target in T cell leukemiaAliza Rosen, Iannis Aifantis
Nature Cancer|February 5, 2022
LILRB3 as a regulator of AML survivalAudrey Lasry, Iannis Aifantis
Cancer Cell|March 12, 2015
The pre-BCR to the rescue: therapeutic targeting of pre-B cell ALLThomas Trimarchi, Iannis Aifantis
Blood|January 2, 2025
Vitamin C deprivation puts stem cells to sleepJuan Carlos Balandrán, Iannis Aifantis
Cancer Cell|September 15, 2020
U.S. Biomedical Research Needs More Immigrant Scientists, Not Fewer!Iannis Aifantis, Benjamin G Neel
Pageof 21